Showing results (121-130 of 1,748) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Interleukin-4 enhances the in vitro precursor cell recruitment for tumor-specific T lymphocytes in patients with glioblastomaC Faber, E Terao, E Morga, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanomaY Kawakami, N Dang, X Wang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancerM I Koukourakis, A Giatromanolaki, F Guddo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Phase II study of combined immunotherapy, chemotherapy, and radiotherapy in the postoperative treatment of advanced non-small-cell lung cancerG B Ratto, M A Cafferata, T Scolaro, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor-specific cytotoxic T lymphocyte responses in patients with melanomaR Philip, S E Alters, E Brunette, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
Prolonged skin graft survival by administration of anti-CD80 monoclonal antibody with cyclosporin AM A Ossevoort, K Lorré, L Boon, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanomaS A Soergel, E G MacEwen, D M Vail, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation siteS E Wright, L Kilinski, S Talib, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Reduced recognition of metastatic melanoma cells by autologous MART-1 specific CTL: relationship to TAP expressionJ L Murray, J M Hudson, M I Ross, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cellsA Ribas, L H Butterfield, B Hu, et al.Pageof 175